PROSPECTIVE OBSERVATIONAL STUDY TO EVALUATE THE BENEFITS FOR THE PATIENT ASSOCIATED WITH THE TREATMENT OF PLAQUE PSORIASIS WITH APREMILAST AFTER OTHER SYSTEMIC TREATMENTS IN CONDITIONS OF CLINICAL PRACTICE IN SPAIN (APPROPRIATE Study)
Phase of Trial: Phase IV
Latest Information Update: 06 Feb 2019
At a glance
- Drugs Apremilast (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Acronyms APPROPIATE
- Sponsors Celgene Corporation
- 26 Jul 2018 Last checked against ClinicalTrials.gov.
- 18 Jul 2018 Status changed from not yet recruiting to recruiting.
- 31 May 2018 New trial record